MedVi vs bmiMD: Semaglutide vs Tirzepatide Pricing and Process
Comparing MedVi vs bmiMD quickly: MedVi focuses on compounded semaglutide with a promotional first month of $179 and a fully online, no-clinic process plus 24/7 certified medical support. bmiMD focuses on compounded tirzepatide with multi-month price tiers that drop to $139/month for a 12-month plan and also offers free shipping and 24/7 clinician access. Early verdict: choose MedVi for a low first-month semaglutide entry and a no-clinic workflow; choose bmiMD for lower long-term monthly pricing on tirzepatide with multi-month commitments.
Start MedVi with $179 first month
Key differences at a glance
This comparison highlights three primary differences between MedVi vs bmiMD: medication type offered, pricing structure and commitment required, and ongoing clinical support and process. Both use compounded medications and state that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
1. Medication offered: semaglutide versus tirzepatide
MedVi provides clinically dosed compounded semaglutide only. bmiMD offers compounded GLP-1/GIP tirzepatide. The providers therefore differ in active ingredient focus; MedVi notes semaglutide as the program medication, while bmiMD markets compounded tirzepatide.
2. Pricing structure and long-term cost
MedVi advertises a winter promotional first month at $179 with fast, free shipping, but discloses the ongoing standalone month price at $299 and a three-month plan at $649 (about $216/month). bmiMD lists tiered subscription pricing: $179 month-to-month, $159/month for three months, $149/month for six months, and $139/month for a 12-month plan, with free shipping on every subscription order. For buyers prioritizing the lowest entry cost for semaglutide, MedVi’s $179 promotional month is decisive. For lower long-term monthly equivalents on tirzepatide, bmiMD’s multi-month tiers can reduce the monthly cost as low as $139 with a 12-month commitment.
See bmiMD tirzepatide pricing plans
3. Process and clinical access
MedVi emphasizes a simple online intake with no clinic visits and 24/7 support from certified medical professionals. MedVi uses an online clinician review; OpenLoop Health clinicians meet with individuals after checkout and retain prescribing decisions. bmiMD describes clinician-reviewed online treatment with 24/7 clinician access and online refills and delivery. Both require a licensed clinician to determine medical appropriateness and both operate via telehealth.
4. Shipping, refunds, and commitments
Both providers include free shipping on at least certain offers: MedVi includes fast, free shipping for the promotional month, while bmiMD advertises free subscription shipping on every order. bmiMD states a 100% refundable policy if not eligible for the program; MedVi notes prescriptions are cash-pay and that insurance may reimburse branded options, but MedVi does not bill insurance for compounded medications.
| Criteria | MedVi | bmiMD |
|---|---|---|
| Starting price | Winter promo: $179 first month | $179 month-to-month; $139/mo with 12-month plan |
| Medication type | Compounded semaglutide only | Compounded tirzepatide (GLP-1/GIP) |
| Long-term pricing | Standalone $299; 3-month $649 (~$216/mo) | 3-mo $159/mo; 6-mo $149/mo; 12-mo $139/mo |
| Support and process | Simple online intake, no clinic visits, 24/7 certified medical support | Clinician-reviewed online care, 24/7 clinician access, online refills |
| Shipping and refunds | Fast, free shipping for promo month; no membership fees stated | Free subscription shipping; 100% refundable if not eligible for program |
| Regulatory note | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality | |
How the differences matter
If your priority is the lowest first-month cost for semaglutide with no clinic visits, MedVi’s $179 promotional month and 24/7 certified support structure match that need. If you prefer tirzepatide and want a lower monthly equivalent over time and are willing to commit to multi-month plans, bmiMD’s tiered pricing down to $139/month for a 12-month plan is the distinguishing factor. Both providers rely on clinician review for prescribing and both use compounded medications with the same regulatory limitation that compounded products are not FDA-approved.
Compare bmiMD subscription options
Bottom line and recommendation for MedVi vs bmiMD
MedVi vs bmiMD trade off medication type and pricing model: MedVi is targeted to people seeking compounded semaglutide with a low promotional entry and a fully virtual, no-clinic process; bmiMD is targeted to people seeking compounded tirzepatide with lower long-term monthly pricing when committing to multi-month plans. Both provide online clinician review and 24/7 access, and both state that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Choose based only on the program attributes and pricing that match your priorities.
Choose MedVi if you want a promotional first-month semaglutide entry at $179, a simple online process with no clinic visits, and 24/7 certified medical support.
Choose bmiMD if you want compounded tirzepatide and lower long-term monthly pricing through multi-month plans down to $139/month for a 12-month commitment, plus free subscription shipping.